Literature DB >> 11326305

Attention-deficit hyperactivity disorder and the adrenergic receptors alpha 1C and alpha 2C.

C L Barr1, K Wigg, G Zai, W Roberts, M Malone, R Schachar, R Tannock, J L Kennedy.   

Abstract

The adrenergic system has been hypothesized to be involved in the etiology of attention-deficit hyperactivity disorder (ADHD) based on pharmacological interventions and animal models. Noradrenergic neurons are implicated in the modulation of vigilance, improvement of visual attention, initiation of adaptive response, learning and memory. In this study we tested the genes for two adrenergic receptors, alpha 1C (ADRA1C) located on chromosome 8p11.2, and alpha 2C (ADRA2C) located on chromosome 4p16, as genetic susceptibility factors in ADHD. For the adrenergic receptor alpha 1C we used a C to T polymorphism that results in a change of Cys to Arg at codon 492 for the linkage study. For the adrenergic receptor alpha 2C gene we examined a dinucleotide repeat polymorphism located approximately 6 kb from the gene. We examined these polymorphisms in a sample of 103 families ascertained through an ADHD proband. Using the transmission disequilibrium test, we did not observe biased transmission of any of the alleles of these polymorphisms. We conclude that the alleles at the polymorphisms tested in these two genes are not linked to the ADHD phenotype in this sample of families.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11326305      PMCID: PMC4833494          DOI: 10.1038/sj.mp.4000863

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  22 in total

Review 1.  Subtypes of functional alpha1- and alpha2-adrenoceptors.

Authors:  J R Docherty
Journal:  Eur J Pharmacol       Date:  1998-11-13       Impact factor: 4.432

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  Linkage study of two polymorphisms at the dopamine D3 receptor gene and attention-deficit hyperactivity disorder.

Authors:  C L Barr; K G Wigg; J Wu; C Zai; S Bloom; R Tannock; W Roberts; M Malone; R Schachar; J L Kennedy
Journal:  Am J Med Genet       Date:  2000-02-07

4.  An extended transmission/disequilibrium test (TDT) for multi-allele marker loci.

Authors:  P C Sham; D Curtis
Journal:  Ann Hum Genet       Date:  1995-07       Impact factor: 1.670

5.  Cloning, functional expression and tissue distribution of human cDNA for the alpha 1C-adrenergic receptor.

Authors:  A Hirasawa; K Horie; T Tanaka; K Takagaki; M Murai; J Yano; G Tsujimoto
Journal:  Biochem Biophys Res Commun       Date:  1993-09-15       Impact factor: 3.575

Review 6.  Catecholamines in attention-deficit hyperactivity disorder: current perspectives.

Authors:  S R Pliszka; J T McCracken; J W Maas
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-03       Impact factor: 8.829

7.  Noradrenergic mechanisms in ADHD children with and without reading disabilities: a replication and extension.

Authors:  J M Halperin; J H Newcorn; V H Koda; L Pick; K E McKay; P Knott
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-12       Impact factor: 8.829

8.  Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder.

Authors:  C L Barr; Y Feng; K Wigg; S Bloom; W Roberts; M Malone; R Schachar; R Tannock; J L Kennedy
Journal:  Mol Psychiatry       Date:  2000-07       Impact factor: 15.992

9.  Precise mapping of the brain alpha 2-adrenergic receptor gene within chromosome 4p16.

Authors:  O Riess; U Thies; I Siedlaczck; S Potisek; R Graham; J Theilmann; T Grimm; J T Epplen; M R Hayden
Journal:  Genomics       Date:  1994-01-15       Impact factor: 5.736

10.  Genetic mapping of adrenergic receptor genes in humans.

Authors:  M R Hoehe; B Otterud; W T Hsieh; M M Martinez; D Stauffer; J Holik; W H Berrettini; W F Byerley; E S Gershon; J M Lalouel
Journal:  J Mol Med (Berl)       Date:  1995-06       Impact factor: 4.599

View more
  7 in total

1.  A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11.

Authors:  Matthew N Ogdie; I Laurence Macphie; Sonia L Minassian; May Yang; Simon E Fisher; Clyde Francks; Rita M Cantor; James T McCracken; James J McGough; Stanley F Nelson; Anthony P Monaco; Susan L Smalley
Journal:  Am J Hum Genet       Date:  2003-04-08       Impact factor: 11.025

Review 2.  Molecular genetics of attention deficit hyperactivity disorder.

Authors:  Stephen V Faraone; Eric Mick
Journal:  Psychiatr Clin North Am       Date:  2010-03

3.  Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults.

Authors:  W Retz; M Rösler; C Kissling; S Wiemann; R Hünnerkopf; A Coogan; J Thome; C Freitag
Journal:  J Neural Transm (Vienna)       Date:  2007-11-12       Impact factor: 3.575

4.  Association of ADHD and the Protogenin gene in the chromosome 15q21.3 reading disabilities linkage region.

Authors:  K G Wigg; Y Feng; J Crosbie; R Tannock; J L Kennedy; A Ickowicz; M Malone; R Schachar; C L Barr
Journal:  Genes Brain Behav       Date:  2008-11       Impact factor: 3.449

5.  [Attention deficit hyperactivity disorder in adults. An overview].

Authors:  E Sobanski; B Alm
Journal:  Nervenarzt       Date:  2004-07       Impact factor: 1.214

6.  Effects of atomoxetine on hyper-locomotive activity of the prenatally valproate-exposed rat offspring.

Authors:  Chang Soon Choi; Minha Hong; Ki Chan Kim; Ji-Woon Kim; Sung Min Yang; Hana Seung; Mee Jung Ko; Dong-Hee Choi; Jueng Soo You; Chan Young Shin; Geon Ho Bahn
Journal:  Biomol Ther (Seoul)       Date:  2014-09-30       Impact factor: 4.634

Review 7.  Attention-deficit/hyperactive disorder updates.

Authors:  Miriam Kessi; Haolin Duan; Juan Xiong; Baiyu Chen; Fang He; Lifen Yang; Yanli Ma; Olumuyiwa A Bamgbade; Jing Peng; Fei Yin
Journal:  Front Mol Neurosci       Date:  2022-09-21       Impact factor: 6.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.